The FEI General Assembly has unanimously accepted the recommendations of the FEI List Group and approved the updated Equine Prohibited Substances List for the 2011 season. National Federation delegates applauded spontaneously at the announcement of the vote.
 
The List was put forward by the FEI List Group following a year of consultation with National Federations and experts, and after the highly successful Congress on the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the equine athlete hosted by the FEI in Lausanne, Switzerland in August.
 

Following the success of last month’s FEI Congress on the in-competition use of NSAIDs, free-to-view videos of the entire event are now available on the FEI website here.

The Congress, which received widespread acclaim for the high calibre of speakers and the level of debate, was held at the Olympic Museum in Lausanne, Switzerland on 16/17 August and attracted over 200 delegates from 29 countries.

The FEI Congress on Non-Steroidal Anti-Inflammatory Drugs (NSAID) Usage and Medication in the Equine Athlete has been hailed as an invaluable contribution to the debate on the in-competition use of NSAIDs. In a ground-breaking approach by the FEI, the Congress brought together the most up-to-date scientific data and non-scientific aspects of NSAID usage for over 200 delegates from 29 countries at the two-day Congress, which wound up at the Olympic Museum in Lausanne, Switzerland, today.

The FEI has undertaken a review of the Protocol for Thermography and Clinical Examination (Hypersensitivity of Legs) and, in an effort to further strengthen the Protocol, has issued the following mandatory guidelines to be applied by the Veterinary Commissions appointed for FEI Events.
 
The new guidelines state: